| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.99B | 43.83B | 44.13B | 41.89B | 39.80B | 38.81B |
| Gross Profit | 8.37B | 8.29B | 9.00B | 7.45B | 6.40B | 6.13B |
| EBITDA | 7.97B | 8.01B | 8.93B | 7.51B | 6.69B | 6.58B |
| Net Income | 1.04B | 1.23B | 1.89B | 1.46B | 965.00M | 857.53M |
Balance Sheet | ||||||
| Total Assets | 73.10B | 75.08B | 69.24B | 63.03B | 59.08B | 56.45B |
| Cash, Cash Equivalents and Short-Term Investments | 7.98B | 8.84B | 7.79B | 8.30B | 8.84B | 8.03B |
| Total Debt | 39.34B | 40.97B | 33.90B | 28.65B | 27.26B | 27.15B |
| Total Liabilities | 51.10B | 52.92B | 47.09B | 42.23B | 39.74B | 37.69B |
| Stockholders Equity | 21.82B | 22.40B | 21.96B | 20.33B | 19.16B | 18.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.74B | -3.60B | -952.00M | 1.34B | 3.83B |
| Operating Cash Flow | 0.00 | -585.00M | -180.00M | -14.00M | 4.29B | 5.04B |
| Investing Cash Flow | 0.00 | -4.54B | -3.19B | -1.21B | -2.98B | -1.38B |
| Financing Cash Flow | 0.00 | 6.15B | 2.80B | 398.00M | -588.00M | -2.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥126.00B | 9.20 | ― | 2.85% | 8.02% | 4.39% | |
76 Outperform | ¥14.50B | 7.37 | ― | 3.03% | 5.72% | 60.38% | |
70 Outperform | ¥18.91B | 8.97 | ― | 3.33% | -1.56% | -3.60% | |
68 Neutral | ¥32.36B | 8.57 | ― | 4.66% | -13.01% | 9.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥42.57B | 6.79 | ― | 3.90% | 0.17% | 58.30% |